Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

1.

Phase II randomized trial of carboplatin and gemcitabine with or without dexamethasone pre-treatment in patients with Stage IV non-small cell lung cancer.

Rinehart J, Arnold S, Kloecker G, Lim A, Zaydan MA, Baeker T, Maheshwari JG, Carloss H, Slone S, Shelton B, Croley J, Kvale E, Brooks M, Leggas M.

Cancer Chemother Pharmacol. 2013 May;71(5):1375-83. doi: 10.1007/s00280-013-2111-3. Epub 2013 Mar 9.

PMID:
23475103
[PubMed - indexed for MEDLINE]
2.

Randomized phase II study of carboplatin/gemcitabine versus vinorelbine/gemcitabine in patients with advanced nonsmall cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) 0104.

Yamamoto N, Nakagawa K, Uejima H, Sugiura T, Takada Y, Negoro S, Matsui K, Kashii T, Takada M, Nakanishi Y, Kato T, Fukuoka M; West Japan Thoracic Oncology Group (WJTOG).

Cancer. 2006 Aug 1;107(3):599-605.

PMID:
16804877
[PubMed - indexed for MEDLINE]
Free Article
3.

A randomized phase II trial using two different treatment schedules of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer.

Masters GA, Argiris AE, Hahn EA, Beck JT, Rausch PG, Ye Z, Monberg MJ, Bloss LP, Curiel RE, Obasaju CK.

J Thorac Oncol. 2006 Jan;1(1):19-24.

PMID:
17409822
[PubMed - indexed for MEDLINE]
4.

Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinoma.

Danson S, Middleton MR, O'Byrne KJ, Clemons M, Ranson M, Hassan J, Anderson H, Burt PA, Fairve-Finn C, Stout R, Dowd I, Ashcroft L, Beresford C, Thatcher N.

Cancer. 2003 Aug 1;98(3):542-53.

PMID:
12879472
[PubMed - indexed for MEDLINE]
Free Article
5.

Gemcitabine and cisplatin versus vinorelbine and cisplatin versus ifosfamide+gemcitabine followed by vinorelbine and cisplatin versus vinorelbine and cisplatin followed by ifosfamide and gemcitabine in stage IIIB-IV non small cell lung carcinoma: a prospective randomized phase III trial of the Gruppo Oncologico Italia Meridionale.

Gebbia V, Galetta D, Caruso M, Verderame F, Pezzella G, Valdesi M, Borsellino N, Pandolfo G, Durini E, Rinaldi M, Loizzi M, Gebbia N, Valenza R, Tirrito ML, Varvara F, Colucci G; Gruppo Ocologico Italia Meridionale.

Lung Cancer. 2003 Feb;39(2):179-89.

PMID:
12581571
[PubMed - indexed for MEDLINE]
6.

Adding gemcitabine to paclitaxel/carboplatin combination increases survival in advanced non-small-cell lung cancer: results of a phase II-III study.

Paccagnella A, Oniga F, Bearz A, Favaretto A, Clerici M, Barbieri F, Riccardi A, Chella A, Tirelli U, Ceresoli G, Tumolo S, Ridolfi R, Biason R, Nicoletto MO, Belloni P, Veglia F, Ghi MG.

J Clin Oncol. 2006 Feb 1;24(4):681-7. Erratum in: J Clin Oncol. 2006 May 10;24(14):2220.

PMID:
16446341
[PubMed - indexed for MEDLINE]
Free Article
7.

Phase II study of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer.

Wang LR, Huang MZ, Zhang GB, Xu N, Wu XH.

Cancer Chemother Pharmacol. 2007 Sep;60(4):601-7. Epub 2007 Jun 5.

PMID:
17549479
[PubMed - indexed for MEDLINE]
8.

Preclinical and clinical evaluation of four gemcitabine plus carboplatin schedules as front-line treatment for stage IV non-small-cell lung cancer.

Bajetta E, Stani SC, De Candis D, Zaffaroni N, Zilembo N, Cortinovis D, Aglione S, Mariani L, Formisano B, Bidoli P.

Ann Oncol. 2003 Feb;14(2):242-7.

PMID:
12562651
[PubMed - indexed for MEDLINE]
Free Article
9.

A phase III randomized trial of gemcitabine-oxaliplatin versus carboplatin-paclitaxel as first-line therapy in patients with advanced non-small cell lung cancer.

Weissman CH, Reynolds CH, Neubauer MA, Pritchard S, Kobina S, Asmar L.

J Thorac Oncol. 2011 Feb;6(2):358-64. doi: 10.1097/JTO.0b013e3181ffe8ef.

PMID:
21206386
[PubMed - indexed for MEDLINE]
10.

A randomized, phase III multicenter trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin in patients with advanced or metastatic non-small-cell lung cancer.

Treat JA, Gonin R, Socinski MA, Edelman MJ, Catalano RB, Marinucci DM, Ansari R, Gillenwater HH, Rowland KM, Comis RL, Obasaju CK, Belani CP; Alpha Oncology Research Network.

Ann Oncol. 2010 Mar;21(3):540-7. doi: 10.1093/annonc/mdp352. Epub 2009 Oct 15.

PMID:
19833819
[PubMed - indexed for MEDLINE]
Free Article
11.

Second-line paclitaxel/carboplatin versus vinorelbine/carboplatin in patients who have advanced non-small-cell lung cancer pretreated with non-platinum-based chemotherapy: a multicenter randomized phase II study.

Pallis AG, Syrigos K, Kotsakis A, Karachaliou N, Polyzos A, Chandrinos V, Varthalitis I, Christophyllakis C, Ardavanis A, Vamvakas L, Vardakis N, Saridaki Z, Samonis G, Giassas S, Georgoulias V, Agelaki S.

Clin Lung Cancer. 2011 Mar;12(2):100-5. doi: 10.1016/j.cllc.2011.03.004. Epub 2011 Apr 11.

PMID:
21550556
[PubMed - indexed for MEDLINE]
12.

A randomized phase II trial of adjuvant chemotherapy with bi-weekly carboplatin plus paclitaxel versus carboplatin plus gemcitabine in patients with completely resected non-small cell lung cancer.

Uramoto H, Nakanishi R, Nagashima A, Uchiyama A, Inoue M, Osaki T, Yoshimatsu T, Sakata H, Nakanishi K, Yasumoto K.

Anticancer Res. 2010 Nov;30(11):4695-9.

PMID:
21115926
[PubMed - indexed for MEDLINE]
13.

Randomized phase II study of carboplatin-paclitaxel or gemcitabine-vinorelbine in patients with advanced nonsmall cell lung cancer and a performance status of 2: West Japan Thoracic Oncology Group 0004.

Saito H, Nakagawa K, Takeda K, Iwamoto Y, Ando M, Maeda M, Katakami N, Nakano T, Kurata T, Fukuoka M.

Am J Clin Oncol. 2012 Feb;35(1):58-63. doi: 10.1097/COC.0b013e318201a0f3.

PMID:
21293243
[PubMed - indexed for MEDLINE]
14.

Gemcitabine (GEM) and carboplatin (CBDCA) versus cisplatin (CDDP) and vinblastine (VLB) in advanced non-small-cell lung cancer (NSCLC) stages III and IV: a phase III randomised trial.

Grigorescu AC, Draghici IN, Nitipir C, Gutulescu N, Corlan E.

Lung Cancer. 2002 Jul;37(1):9-14.

PMID:
12057861
[PubMed - indexed for MEDLINE]
15.

Gemcitabine in brief versus prolonged low-dose infusion, both combined with carboplatin for advanced non-small cell lung cancer.

Beniwal SK, Patel KM, Shukla S, Parikh BJ, Shah S, Patel A.

Indian J Cancer. 2012 Apr-Jun;49(2):202-8. doi: 10.4103/0019-509X.102861.

PMID:
23107971
[PubMed - indexed for MEDLINE]
Free Article
16.
17.

Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial.

Zatloukal P, Petruzelka L, Zemanová M, Kolek V, Skricková J, Pesek M, Fojtů H, Grygárková I, Sixtová D, Roubec J, Horenková E, Havel L, Průsa P, Nováková L, Skácel T, Kůta M.

Lung Cancer. 2003 Sep;41(3):321-31.

PMID:
12928123
[PubMed - indexed for MEDLINE]
18.

Phase I-II study of gemcitabine and carboplatin in stage IIIB-IV non-small-cell lung cancer.

Iaffaioli RV, Tortoriello A, Facchini G, Caponigro F, Gentile M, Marzano N, Gravina A, Dimitri P, Costagliola G, Ferraro A, Ferrante G, De Marino V, Illiano A.

J Clin Oncol. 1999 Mar;17(3):921-6.

PMID:
10071285
[PubMed - indexed for MEDLINE]
Free Article
19.

Rational drug sequencing of paclitaxel, gemcitabine and carboplatin in patients with untreated stage IV and select stage IIIB non-small cell lung cancer.

Sovak MA, Lutzker S, Zheng L, Guensch L, Joyce M, Schwartz S, Wu Y, Aisner J.

Lung Cancer. 2006 Aug;53(2):177-81. Epub 2006 Jun 21.

PMID:
16790293
[PubMed - indexed for MEDLINE]
20.

Intensive anti-inflammatory therapy with dexamethasone in patients with non-small cell lung cancer: effect on chemotherapy toxicity and efficacy.

Leggas M, Kuo KL, Robert F, Cloud G, deShazo M, Zhang R, Li M, Wang H, Davidson S, Rinehart J.

Cancer Chemother Pharmacol. 2009 Mar;63(4):731-43. doi: 10.1007/s00280-008-0767-x. Epub 2008 May 24.

PMID:
18500521
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk